Skip to Main content Skip to Navigation
Journal articles

Saccharomyces boulardii effects on gastrointestinal diseases

Abstract : Health benefits attributed to probiotics have been described for decades. They include the treatment and the prevention of gastrointestinal diseases, vaginal and urinary infections and allergies. Saccharomyces boulardii, a species of yeast widely distributed, has been described as a biotherapeutic agent since several clinical trials displayed its beneficial effects in the prevention and the treatment of intestinal infections and in the maintenance of inflammatory bowel disease. All these diseases are characterized by acute diarrhoea. Administration of the yeast in combination or not with an antibiotherapy has shown to decrease significantly the duration and the frequency of diarrhoea. Experimental studies elucidated partially the molecular mechanisms triggered to improve the host health. The discovery of its anti-inflammatory and immuno-modulatory activities in correlation with the advances in the understanding of mucosal immunology opens a new field of perspectives in S. boulardii therapeutic applications.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-02654771
Contributor : Migration Prodinra Connect in order to contact the contributor
Submitted on : Friday, May 29, 2020 - 9:49:21 PM
Last modification on : Thursday, May 6, 2021 - 2:22:53 PM

Links full text

Identifiers

Collections

Citation

Galliano Zanello, Francois Meurens, Mustapha Berri, Henri Salmon. Saccharomyces boulardii effects on gastrointestinal diseases. Current Issues in Molecular Biology, Horizon Scientific Press, 2008, 11, pp.47-58. ⟨10.21775/cimb.011.047⟩. ⟨hal-02654771⟩

Share

Metrics

Record views

14